95272-99-4 Usage
Description
()-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-6,8-dimethyl-4-benzopyrone, also known as leucocyanidin or leucoanthocyanidin, is a flavonoid compound found in certain fruits, vegetables, and beverages. It is a colorless, water-soluble compound with antioxidant properties and potential health benefits. Leucocyanidin is known for its anti-inflammatory, anti-cancer, and cardioprotective effects, as well as its ability to regulate blood sugar levels and improve cognitive function. It also plays a role in the coloration of flowers and fruits, as it can be converted into anthocyanidins, which are responsible for the red, blue, and purple pigments in plants.
Uses
Used in Health and Nutrition Industry:
Leucocyanidin is used as a dietary supplement for its potential health benefits, including anti-inflammatory, anti-cancer, and cardioprotective effects. It may also help regulate blood sugar levels and improve cognitive function.
Used in Agriculture:
Leucocyanidin is used in agriculture for its role in the coloration of flowers and fruits, as it can be converted into anthocyanidins, which are responsible for the red, blue, and purple pigments in plants. This can enhance the visual appeal and marketability of these plants.
Check Digit Verification of cas no
The CAS Registry Mumber 95272-99-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,2,7 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 95272-99:
(7*9)+(6*5)+(5*2)+(4*7)+(3*2)+(2*9)+(1*9)=164
164 % 10 = 4
So 95272-99-4 is a valid CAS Registry Number.
95272-99-4Relevant articles and documents
Synthesis and biological activity of flavanone derivatives
Shi, Lei,Feng, Xiu E,Cui, Jing Rong,Fang, Lian Hua,Du, Guan Hua,Li, Qing Shan
scheme or table, p. 5466 - 5468 (2011/01/03)
A series of new flavanone derivatives of farrerol was synthesized by a convenient method. The in vitro anti-tumor activity of these compounds was evaluated against human Bel-7402, HL-60, BGC-823 and KB cell lines, the protein tyrosine kinase (PTK) inhibitor activity was also tested. Their cytoprotective activity was tested using hydrogen peroxide (H2O2)-induced injury in human umbilical vein endothelial cells. Their in vitro anti-atherosclerosis activity was tested on vascular smooth muscle cells by the MTT method using tetrandrine as a positive contrast drug. The structures of all compounds synthesized were confirmed by 1H, 13C NMR and ESI-MS. Most of the compounds exhibited good pharmacological activity and the preliminary structure-activity relationships were described.
